To examine the association between hypnotic agents and cardiovascular outcomes specifically in individuals suffering from insomnia.
Key Findings:
No significant association between Z-meds and coronary heart disease (CHD), stroke, or cardiovascular mortality was found.
Benzodiazepine use significantly increased the risk of CHD, heart failure (HF), and cardiovascular mortality.
Sensitivity analyses confirmed the robustness of these associations.
Interpretation:
The study indicates heterogeneous associations between different categories of hypnotics and cardiovascular events, highlighting that benzodiazepines pose a cardiovascular risk while Z-meds appear safe for insomnia patients.
